We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
+7.96%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$78.8B
AUM Growth
-$135M
(-0.17%)
Cap. Flow
-$4.13B
Cap. Flow
% of AUM
-5.25%
Top 10 Holdings %
Top 10 Hldgs %
14.64%
Holding
3,669
New
809
Increased
1,002
Reduced
1,102
Closed
643
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$807M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$497M |
| 3 |
RNAM
Avidity Biosciences
RNAM
|
+$390M |
| 4 |
Kenvue
KVUE
|
+$379M |
| 5 |
Broadcom
AVGO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$409M |
| 2 |
Visa
V
|
+$354M |
| 3 |
Advanced Micro Devices
AMD
|
+$328M |
| 4 |
Meta Platforms (Facebook)
META
|
+$317M |
| 5 |
Lockheed Martin
LMT
|
+$316M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.61% |
| 2 | Consumer Discretionary | 9.64% |
| 3 | Healthcare | 8.17% |
| 4 | Industrials | 8.1% |
| 5 | Financials | 8.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Idexx Laboratories
IDXX
$44.7B
| $876K | ﹤0.01% |
1,295
-1,920
| -60% | -$1.31M |
|
2202
CALL
Applied Optoelectronics
AAOI
$11B
| $872K | ﹤0.01% |
25,000
| – | – |
|
2203
Old Dominion Freight Line
ODFL
$44.7B
| $870K | ﹤0.01% |
5,546
+3,612
| +187% | +$518K |
|
2204
ArriVent BioPharma
AVBP
$1.4B
| $866K | ﹤0.01% |
+43,030
| New | +$896K |
|
2205
Upstart Holdings
UPST
$3.01B
| $862K | ﹤0.01% |
19,712
-268,052
| -93% | -$12.3M |
|
2206
PACCAR
PCAR
$68.8B
| $861K | ﹤0.01% |
+7,860
| New | +$805K |
|
2207
CALL
Blackrock
BLK
$183B
| $856K | ﹤0.01% |
800
-200
| -20% | -$219K |
|
2208
RxSight
RXST
$292M
| $853K | ﹤0.01% |
81,836
-252,341
| -76% | -$2.53M |
|
2209
PUT
lululemon athletica
LULU
$13.6B
| $852K | ﹤0.01% |
4,100
-9,200
| -69% | -$1.67M |
|
2210
PUT
Transmedics
TMDX
$3.11B
| $852K | ﹤0.01% |
+7,000
| New | +$878K |
|
2211
CALL
Sabre
SABR
$892M
| $850K | ﹤0.01% |
+625,000
| New | +$1.08M |
|
2212
Ultrapar
UGP
$6.55B
| $849K | ﹤0.01% |
225,270
+44,200
| +24% | +$175K |
|
|
FOLD
2213
CALL
DELISTED
Amicus Therapeutics
FOLD
| $847K | ﹤0.01% |
+59,500
| New | +$585K |
|
2214
Zoetis
ZTS
$31.3B
| $842K | ﹤0.01% |
+6,695
| New | +$873K |
|
|
SEM
2215
DELISTED
Select Medical
SEM
| $839K | ﹤0.01% |
+56,491
| New | +$798K |
|
2216
Forward Air
FWRD
$682M
| $839K | ﹤0.01% |
+33,544
| New | +$755K |
|
2217
Napco Security Technologies
NSSC
$1.37B
| $838K | ﹤0.01% |
+20,097
| New | +$846K |
|
2218
Aurora
AUR
$13.4B
| $836K | ﹤0.01% |
217,682
+199,713
| +1,111% | +$914K |
|
2219
CALL
Cleveland-Cliffs
CLF
$6.93B
| $834K | ﹤0.01% |
62,800
-500,000
| -89% | -$6.31M |
|
|
CNL
2220
Collective Mining Ltd. Common Shares
CNL
$1.35B
| $833K | ﹤0.01% |
+57,187
| New | +$696K |
|
2221
CALL
Wendy's
WEN
$1.65B
| $833K | ﹤0.01% |
100,000
| – | – |
|
2222
PUT
Zeta Global
ZETA
$7.44B
| $830K | ﹤0.01% |
+40,800
| New | +$762K |
|
2223
PUT
AST SpaceMobile
ASTS
$21.4B
| $828K | ﹤0.01% |
11,400
-21,000
| -65% | -$1.5M |
|
|
NOTV
2224
DELISTED
Inotiv
NOTV
| $827K | ﹤0.01% |
1,471,849
+486,113
| +49% | +$508K |
|
2225
Bank OZK
OZK
$5.7B
| $824K | ﹤0.01% |
17,911
-571,236
| -97% | -$26.7M |
|
Similar funds
BC
Balyasny Asset Management's Q4 2025 Portfolio in Review
As of Q4 2025, Balyasny Asset Management held 3,669 positions worth $78.8B, down 0.17% from $78.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Balyasny Asset Management withdrew a net $4.13B in Q4 2025, closing 643 positions and reducing 1,102 holdings. Its most notable exit was Mr. Cooper, an estimated $277M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Balyasny Asset Management opened a new position in Avidity Biosciences worth $436M.
- Balyasny Asset Management's largest Q4 2025 buy was Avidity Biosciences: 6,040,590 shares worth $436M.
- Balyasny Asset Management added most to Amazon in Q4 2025, an estimated $807M increase.
- Balyasny Asset Management's biggest Q4 2025 reduction was Apple, cutting an estimated $409M.
- Balyasny Asset Management fully exited Mr. Cooper in Q4 2025, selling an estimated $277M.
- Balyasny Asset Management's ten largest holdings make up 15% of its $78.8B portfolio in Q4 2025.
- Balyasny Asset Management opened 809 new positions and closed 643 in Q4 2025.
- Balyasny Asset Management's portfolio value fell 0.17% quarter-over-quarter to $78.8B.
Based on Balyasny Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.